Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Hugo Gene measured Rank description expected final
Results: HTML CSV LaTeX
Showing element 501 to 550 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
final\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGAP10\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0163276\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1623\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.0681463\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.23959628\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGAP21\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0500251\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
426\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RHO-GTPASE ACTIVATING PROTEIN 10. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.180355\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.277370187\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGAP23\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0397949\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
424\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.143472\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.277370497\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGAP26\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0203871\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1622\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
OLIGOPHRENIN-1 LIKE PROTEIN (GTPASE REGULATOR ASSOCIATED WITH FOCAL ADHESION KINASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.0850893\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.239596518\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGEF3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0223435\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1527\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 3; RHOGEF PROTEIN; 59.8 KDA PROTEIN; EXCHANGE FACTOR FOUND IN PLATELETS AND LEUKEMIC AND NEURONAL TISSUES, XPLN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.0922076\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.242317336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGEF4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0362539\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2091\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 ISOFORM A; APC-STIMULATED GUANINE NUCLEOTIDE EXCHANGE FACTOR. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.158511\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.228715357\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGEF6\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.257131\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2181\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6 (PAK-INTERACTING EXCHANGE FACTOR ALPHA) (ALPHA-PIX) (COOL-2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13453\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.226640988\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGEF7\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.214133\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7 (PAK-INTERACTING EXCHANGE FACTOR BETA) (BETA-PIX) (COOL-1) (P85). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.945656\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.226438578\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARHGEF9\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0307532\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2089\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CDC42 GUANINE EXCHANGE FACTOR 9; HPEM-2 COLLYBISTIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.13446\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.228716347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARID1A\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.182783\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
113\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"SWI/SNF-RELATED, MATRIX-ASSOCIATED, ACTIN-DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY F MEMBER 1 (SWI-SNF COMPLEX PROTEIN P270) (B120). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.506093\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.361164845\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARID1B\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.155731\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
115\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BRG1-BINDING PROTEIN ELD/OSA1; ELD (EYELID)/OSA PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.431206\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.36115221\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARID4B\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.403732\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1373\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.64923\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.244800301\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARL1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0394801\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1566\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.163824\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.240990941\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARL3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.038359\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1822\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 3. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.163741\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.234266311\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARL4A\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0296714\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1549\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 4. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.122715\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.241791142\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARL6IP5\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.104678\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2913\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYTOSKELETON RELATED VITAMIN A RESPONSIVE PROTEIN; GLUTAMATE TRANSPORTER EEAC1-ASSOCIATED PROTEIN; DERMAL PAPILLA DERIVED PROTEIN 11; PUTATIVE MAPK ACTIVATING PROTEIN PM27. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.601977\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.173890365\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARMET\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0869714\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2496\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARMET PROTEIN PRECURSOR (ARGININE-RICH PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.403767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.215399971\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARPC1A\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.355858\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
724\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 1A (SOP2-LIKE PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3445\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.264676832\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARPC1B\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.317947\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
732\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARP2/3 COMPLEX 41 KDA SUBUNIT (P41-ARC) (ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 1B). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.20127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.264675718\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARPC2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.427564\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
778\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARP2/3 COMPLEX 34 KDA SUBUNIT (P34-ARC) (ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.62441\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.263211874\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARPC3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.392968\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
725\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARP2/3 COMPLEX 21 KDA SUBUNIT (P21-ARC) (ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 3). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.48471\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.264676604\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARPC5\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.402903\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
717\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARP2/3 COMPLEX 16 KDA SUBUNIT (P16-ARC) (ACTIN-RELATED PROTEIN 2/3 COMPLEX SUBUNIT 5). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.52156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.264795999\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARPC5L\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.424703\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
719\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.60405\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.264769178\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARRB1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.282189\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2985\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"BETA-ARRESTIN 1 (ARRESTIN, BETA 1). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04196\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.138195165\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARRB2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.240182\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2988\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
"BETA-ARRESTIN 2 (ARRESTIN, BETA 2). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.738\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.138194476\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ARRDC2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1.02292\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
879\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
3.93312\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.260078513\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
ARRDC3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0467541\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1562\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
0.193844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.241194466\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
ARRDC4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0442559\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1561\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
0.183485\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.241196283\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ASAH1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.083902\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1618\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ACID CERAMIDASE PRECURSOR (EC 3.5.1.23) (ACYLSPHINGOSINE DEACYLASE) (N-ACYLSPHINGOSINE AMIDOHYDROLASE) (AC) (PUTATIVE 32 KDA HEART PROTEIN) (PHP32). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.35015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.239617307\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ASCC1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.343832\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1044\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.3576\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.253264585\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ASCC2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0336999\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ASC-1 COMPLEX SUBUNIT P100. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.139062\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.242337231\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ASL\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.255929\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2243\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARGININOSUCCINATE LYASE (EC 4.3.2.1) (ARGINOSUCCINASE) (ASAL). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14373\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.223766973\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ASNS\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0326245\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1697\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ASPARAGINE SYNTHETASE [GLUTAMINE-HYDROLYZING] (EC 6.3.5.4) (GLUTAMINE- DEPENDENT ASPARAGINE SYNTHETASE) (TS11 CELL CYCLE CONTROL PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.137154\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.237867652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ASNSD1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0338955\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1699\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
HCV NS3-TRANSACTIVATED PROTEIN 1. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.142498\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.237866496\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ASS1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.161564\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1778\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ARGININOSUCCINATE SYNTHASE (EC 6.3.4.5) (CITRULLINE--ASPARTATE LIGASE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.685844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.235569605\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATAD1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.153382\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2756\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.756695\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.202699899\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATF2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.673422\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
586\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYCLIC-AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-2 (ACTIVATING TRANSCRIPTION FACTOR 2) (CAMP RESPONSE ELEMENT BINDING PROTEIN CRE- BP1) (HB16). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.49889\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.269488453\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATF3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.101196\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
182\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYCLIC-AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-3 (ACTIVATING TRANSCRIPTION FACTOR 3). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.30217\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.334897574\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATF6\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0417611\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1343\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYCLIC-AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-6 ALPHA (ACTIVATING TRANSCRIPTION FACTOR 6 ALPHA) (ATF6-ALPHA). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.170257\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.24528272\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATF7\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.574984\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
587\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYCLIC-AMP-DEPENDENT TRANSCRIPTION FACTOR ATF-7 (ACTIVATING TRANSCRIPTION FACTOR 7) (TRANSCRIPTION FACTOR ATF-A). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.13394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.269447126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATG12\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.196655\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2229\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AUTOPHAGY PROTEIN 12-LIKE (APG12-LIKE). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.876663\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.224322231\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATG16L1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.515003\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
302\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.71949\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.299509157\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\parbox{\wcA}{\vspace{3pt}\noindent
ATG16L2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.329649\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
305\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1.10466\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.298416707\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATG3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.206188\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3000\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
APG3P; PC3-96 PROTEIN. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.59883\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.128961803\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATG4A\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.156084\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3067\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYSTEINE ENDOPEPTIDASE AUT-LIKE 2 ISOFORM A; AUTOPHAGY-RELATED CYSTEINE ENDOPEPTIDASE 2; AUTOPHAGIN 2. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.50787\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.103512902\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATG4B\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.126175\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3064\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
CYSTEINE ENDOPEPTIDASE AUT-LIKE ISOFORM B. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.21767\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.103620028\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATG5\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.40611\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
653\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
AUTOPHAGY PROTEIN 5-LIKE (APG5-LIKE) (APOPTOSIS-SPECIFIC PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.51635\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.267820754\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATIC\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.100408\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1553\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
BIFUNCTIONAL PURINE BIOSYNTHESIS PROTEIN PURH [INCLUDES: PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE FORMYLTRANSFERASE (EC 2.1.2.3) (AICAR TRANSFORMYLASE); IMP CYCLOHYDROLASE (EC 3.5.4.10) (INOSINICASE) (IMP SYNTHETASE) (ATIC)]. \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.416\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.241365385\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATN1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.13427\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
417\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
ATROPHIN-1 (DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY PROTEIN). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.484077\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.277373228\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ATP11A\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
0.0225037\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1083\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
POTENTIAL PHOSPHOLIPID-TRANSPORTING ATPASE IH (EC 3.6.3.1) (ATPASE CLASS I TYPE 11A) (ATPASE IS). \vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.0892747\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
0.252072536\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/